Vancomycin-resistant Enterococcus faecium derived from animals colonizing the human gut: The missing evidence?

Clinical Microbiology and Infection

Volumn 5, Issue 2, 1999, Pages 64-66

  Goossens, Herman ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AVILAMYCIN; AVOPARCIN; BACITRACIN; EVERNIMICIN; EVERNINOMICIN; GROWTH PROMOTOR; PROBIOTIC AGENT; TEICOPLANIN; TYLOSIN; UNCLASSIFIED DRUG; VANCOMYCIN; VIRGINIAMYCIN;

AGRICULTURE; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENE; ENTEROCOCCUS FAECIUM; FECES CULTURE; HUMAN; INGESTION; INTESTINE FLORA; NONHUMAN; POULTRY; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SHORT SURVEY; SWINE; TRANSPOSON;

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECIUM; SUS SCROFA;

EID: 0033023601     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00104.x     Document Type: Article

References (14)

1. Berchieri A. Intestinal colonization of a human subject by vancomycin-resistant Enterococus faecium. Clin Microbiol Infect 1998; 5: 97-100.
2. Descheemaeker P, Chapelle S, Vandamme P, Goossens H. Transfer of Tn1546 or related elements conferring high level glycopepride resistance among enterococci from animal and human hosts [abstract 1D-25]. In: Program and abstracts of 5th ASM Conference on Streptococcal Genetics, Vichy, France. Washington, DC: American Society for Microbiology, 1998: 62.
3. Van den Boogaard AE, Jensen LB, Stobberingh EE. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med 1997; 21: 1558-9.
4. Nelson RRS. Selective isolation of vancomycin-resistant enterococci. J Hosp Infect 1998; 39: 13-18.
5. Handwerger S, Skoble J. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1995; 39: 2446-53.
6. Van der Auwera P, Pensart N, Korten V, Murray BE, Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996; 173: 1129-36.
7. Duval-Iflah Y, Gainche I, Ouriet M, Lett M, Hubert J. Recombinant DNA transfer to Escherichia coli of human faecal origin in vitro and in digestive tract of gnotobiotic mice. FEMS Microbiol Lett 1994; 15: 79-88.
8. Van den Braak N, van Belkum A, van Keulen M, Vliegenthart J, Verbrugh HA, Endtz HP. Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in The Netherlands. J Clin Microbiol 1998; 36: 1927-32.
9. Woodford N, Adebiyi AA, Palepou MF, Cookson BD. Diversity of vanA glycopeptide resistance elements in enterococci from humans and nonhuman sources. Antimicrob Agents Chemother 1998; 42: 502-8.
10. Jensen LB, Ahrens P, Dons L, Jones RN, Hammerum AM, Aarestrup FM. Molecular analysis of Tn1546 in Enterococcus faecium isolated from animals and humans. J Clin Microb 1998; 36: 437-42.
11. Devriese LA. Streptococcal ecovars associated with different animal species: epidemiological significance of serogroups and biotypes. J Appl Bacteriol 1991; 71: 478-83.
12. Mertz JL, Peloso JS, Barker BJ, et al. Isolation and structural identification of nine avilamycins. J Antibiot 1986; 19: 877-87.
13. Urban C, Mariano N, Mosinka-Snipas K, Wadee T, Chahrour T, Rahal JJ. Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin. J Antimicrob Chemother 1990; 37: 361-4.
14. Aarestrup FM. Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin. Microb Drug Res 1998; 4: 137-42.